Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial

INTRODUCTION: Smoking may reduce the efficacy of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD), but its impact on bronchodilator efficacy is unclear. This analysis of the EMAX trial explored efficacy and safety of dual- versus mono-bronchodilator therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjermer, Leif H., Boucot, Isabelle H., Vogelmeier, Claus F., Maltais, François, Jones, Paul W., Tombs, Lee, Compton, Chris, Lipson, David A., Kerwin, Edward M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408076/
https://www.ncbi.nlm.nih.gov/pubmed/34347255
http://dx.doi.org/10.1007/s12325-021-01855-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408076/
https://www.ncbi.nlm.nih.gov/pubmed/34347255
http://dx.doi.org/10.1007/s12325-021-01855-y

Ejemplares similares